She has held senior leadership roles at Eli Lilly, Elanco and Astellas Pharma, where she has focused on building and scaling global capability centres, managing regulated operations and driving cross-border initiatives. She has also held industry-level board roles with organisations including OPPI, CII, NASSCOM and the Biotechnology Vision Group
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.